A clinical trial to study the effect of individualised homoeopathic medicine (similimum) on modifying the anger of patients having mild to moderate essential hypertension and thereby reducing the raised blood pressure against standard antihypertensive treatment

A double-blind, placebo controlled, randomised trial using individualised homoeopathic treatment for modifying anger and thereby reducing blood pressure in patients of essential hypertension against standard care treatment - MAEHT

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021507

Enrollment

350

Registered

2019-10-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Individualised homoeopathic remedy: be done and individualised homoeopathic remedy will be prescribed depending on the totality of symptoms It will be administered in the form of medici

Eligibility

Inclusion criteria

Inclusion criteria: Patients of essential hypertension

Exclusion criteria

Exclusion criteria: Patients having secondary hypertension Pregnant and lactating women Uncontrolled endocrine disorders Severe psychiatric disorder

Design outcomes

Primary

Measure	Time frame
Changes in anger variables scores Changes in blood pressure valuesTimepoint: At the end of 6 months study period	—

Secondary

Measure	Time frame
Reduction in the intensity of comorbid conditionsTimepoint: Follow up every 2 weeks to assess subjective and objective criteria	—

Countries

India

Contacts

Public ContactDr LEENA BAGADIA

Dr.M.L.Dhawale Memorial Homoeopathic Institute and Hospital

leenabagadia@gmail.com09870098982

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026